Skip to content

Room Air a Safe Alternative to Dye Injection in Ureterography

Room Air vs Iohexol Injection in URS

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06110299
Enrollment
24
Registered
2023-10-31
Start date
2023-10-29
Completion date
2023-12-29
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral Obstruction

Brief summary

The procedure began in the Thirties .Retrograde pyelography is an essential step in most endoscopic procedure. This procedure is used as an investigation, with different indication in the past and the present, to delineate the ureter and pelvicalyceal system either before or after the operation, for example to detect any complication as a perforation and the need for stent placement. The procedure has an alternative, less invasive, the IVP. Multiple articles explored the use of air in the puncture of PCNL and to identify the posterior calyx, but to our knowledge there is no articles addressed the idea of air injection in the ureter. The greatest fear is air embolism or non-visualization of the ureter. The availability and cost of contrast material may be a problem, most urologist face

Detailed description

Our aim is to explore the feasibility of using Room air as a contrast material and check the safety of this procedure. Materials and methods: A pilot study in Assiut university hospital Urology department to evaluate the efficacy of air injection as a replacement dye injection in cases of endoscopy either in emergency or elective situation. Twenty patients were selected randomly, to evaluate the impact of retrograde pyelography (RPG) using air in cases of obstructed ureters and raised renal function.

Interventions

DIAGNOSTIC_TESTair injection

delination of the ureter and pelvis by injecting air under C-ARM

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all patients undergoing Urs

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frame
no air embolism3 months

Secondary

MeasureTime frame
identification of ureterintraoperative

Contacts

Primary Contactabdelrahman M abdelkader
abdelrahmanmohamed.aa@aun.edu.eg01068336396

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026